Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SHE:300937)
China flag China · Delayed Price · Currency is CNY
37.59
+1.59 (4.42%)
Jan 23, 2026, 4:00 PM EST

SHE:300937 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Jan '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2016 - 2019
3,5212,3943,0092,7614,358-
Upgrade
Market Cap Growth
44.48%-20.45%8.97%-36.64%--
Upgrade
Enterprise Value
3,5242,4062,9782,7284,281-
Upgrade
Last Close Price
36.8024.9331.0328.2944.66-
Upgrade
PE Ratio
-146.3250.5465.71680.87-
Upgrade
PS Ratio
0.800.550.680.701.28-
Upgrade
PB Ratio
4.292.813.523.375.53-
Upgrade
P/TBV Ratio
4.533.053.803.705.98-
Upgrade
P/FCF Ratio
-25.07-20.55--
Upgrade
P/OCF Ratio
-18.75-18.09--
Upgrade
EV/Sales Ratio
0.800.550.670.691.26-
Upgrade
EV/EBITDA Ratio
59.7749.7532.0135.22320.29-
Upgrade
EV/EBIT Ratio
121.1782.5240.2646.88117838.91-
Upgrade
EV/FCF Ratio
-76.7525.20-20.31--
Upgrade
Debt / Equity Ratio
0.460.460.390.300.170.08
Upgrade
Debt / EBITDA Ratio
6.386.603.352.977.810.55
Upgrade
Debt / FCF Ratio
-4.07-1.81-1.18
Upgrade
Asset Turnover
2.462.572.702.863.363.53
Upgrade
Inventory Turnover
8.277.428.088.017.998.24
Upgrade
Quick Ratio
0.880.870.800.830.630.60
Upgrade
Current Ratio
1.511.651.721.682.202.04
Upgrade
Return on Equity (ROE)
-0.39%1.80%6.78%4.50%1.03%10.36%
Upgrade
Return on Assets (ROA)
1.02%1.07%2.82%2.62%0.00%4.94%
Upgrade
Return on Invested Capital (ROIC)
-1.12%3.16%8.56%6.88%0.01%12.40%
Upgrade
Return on Capital Employed (ROCE)
3.40%3.30%8.30%6.90%0.00%11.60%
Upgrade
Earnings Yield
-0.17%0.68%1.98%1.52%0.15%-
Upgrade
FCF Yield
-1.30%3.99%-5.01%4.87%-4.26%-
Upgrade
Dividend Yield
0.26%0.40%0.71%0.71%--
Upgrade
Payout Ratio
-184.93%40.51%12.63%322.93%23.40%
Upgrade
Buyback Yield / Dilution
-3.08%-0.21%-0.56%-4.44%-26.94%-0.24%
Upgrade
Total Shareholder Return
-2.81%0.19%0.15%-3.73%-26.94%-0.24%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.